V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10390166 | 10072347 | 1.52 | 83.2 | Curative (C) | 2021-04-12 | 2021-05-29 | IPILIMUMAB + NIVOLUMAB | N | N | CISPLATIN | 100576185 |
| 10392729 | 10072353 | 1.69 | 61 | null | 2017-11-06 | 2019-03-17 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 100025261 |
| 10393798 | 10072354 | 1.57 | 87.4 | 03 | null | 2022-02-16 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 100784295 |
| 10393881 | 10072355 | 1.5 | null | null | 2019-01-17 | 2019-01-17 | Chlorambucil | 02 | null | CHLORAMBUCIL | 101109475 |
| 10394092 | 10072356 | 1.71 | 66.2 | null | 2022-04-20 | 2022-04-20 | Gemcitabine weekly | 02 | null | GEMCITABINE | 101218214 |
| 10394095 | 10072357 | 1.62 | 67.2 | Palliative (P) | 2020-02-28 | 2020-03-06 | CTD Attenuated (Thalidomide 50mg) | 02 | N | DABRAFENIB | 101313413 |
| 10395783 | 10072359 | 1.71 | 57.8 | null | 2022-03-29 | 2022-04-12 | Cyclophosphamide oral | 02 | null | CYCLOPHOSPHAMIDE | 100563493 |
| 10397323 | 10072361 | 1.7 | 108.6 | Palliative (P) | 2017-11-10 | 2017-11-20 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101420043 |
| 10397511 | 10072362 | 1.74 | 71 | null | 2017-09-04 | 2018-06-12 | Bortezomib + Panobinostat | 02 | null | BORTEZOMIB + PANOBINOSTAT | 100559080 |
| 10399803 | 10072364 | 1.72 | 85.4 | Curative (C) | 2019-02-16 | 2020-10-23 | Azacitidine | 02 | N | AZACITIDINE | 100479259 |
| 10404444 | 10072368 | 1.62 | 68.8 | Palliative (P) | 2021-04-01 | 2021-04-13 | PVD | 02 | N | BORTEZOMIB + PANOBINOSTAT | 101732737 |
| 10404614 | 10072369 | 1.75 | 74.4 | Disease modification (D) | 2019-07-24 | 2019-08-28 | Capecitabine (21 day) + Irinotecan | 02 | null | CABOZANTINIB | 101714696 |
| 10406306 | 10072370 | 1.57 | 70 | null | 2019-07-21 | 2020-03-19 | Bortezomib + Panobinostat | 02 | null | BORTEZOMIB + PANOBINOSTAT | 101444411 |
| 10409542 | 10072371 | 1.77 | 87.3 | Palliative (P) | 2021-03-21 | 2021-04-01 | null | 2 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100586671 |
| 10412690 | 10072372 | 1.7 | 90.7 | Curative (C) | 2021-03-05 | 2022-03-28 | GEMCITABINE | 02 | null | GEMCITABINE | 100651306 |
| 10414088 | 10072373 | 0 | 94.4 | Palliative (P) | 2019-08-11 | 2019-10-25 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | CHLORAMBUCIL + OBINUTUZUMAB | 101747330 |
| 10415757 | 10072375 | 1.91 | 85 | null | 2017-02-14 | 2017-03-11 | Bortezomib + Panobinostat | 99 | null | BORTEZOMIB + PANOBINOSTAT | 100657848 |
| 10415900 | 10072376 | 1.73 | 75 | Palliative (P) | 2020-04-09 | 2020-04-20 | Docetaxel + nintedanib | 02 | N | FLUOROURACIL + MITOMYCIN | 101412971 |
| 10417251 | 10072377 | 1.57 | 61.2 | null | 2017-03-13 | 2019-03-23 | FLUOROURACIL + OXALIPLATIN + Trastuzumab | 02 | null | NILOTINIB | 101112452 |
| 10418578 | 10072379 | 1.78 | 86.2 | null | 2020-07-28 | 2020-08-09 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100713107 |
| 10419090 | 10072380 | 1.69 | 74.7 | null | 2020-01-10 | 2020-03-01 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | MYELOMA XI TRIAL | 100035807 |
| 10421926 | 10072381 | 1.5 | 54.7 | 03 | 2020-05-20 | 2020-05-27 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 02 | N | NERATINIB | 101205507 |
| 10422545 | 10072382 | null | null | Palliative (P) | 2016-11-15 | 2018-02-07 | null | 02 | N | ISATUXIMAB + POMALIDOMIDE | 101696199 |
| 10423408 | 10072384 | 1.9 | 89.5 | 03 | 2019-04-26 | 2019-05-10 | Pemetrexed | 99 | N | MERCAPTOPURINE | 101443785 |
| 10425272 | 10072387 | null | null | null | 2019-08-05 | 2019-08-05 | Bendamustine + Thalidomide +/- Dex | 02 | null | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 100998880 |
| 10425742 | 10072388 | 1.74 | 74.3 | null | 2020-04-08 | 2020-04-25 | RIALTO TRIAL | 02 | null | FLUOROURACIL + MITOMYCIN | 101324934 |
| 10425811 | 10072389 | null | null | Palliative (P) | 2022-04-26 | 2022-05-01 | Dasatinib | 02 | N | DURVALUMAB | 100147381 |
| 10426029 | 10072390 | null | null | null | 2019-02-10 | 2019-02-24 | PEG INTERFERON | 02 | null | CAPECITABINE + MITOMYCIN | 101147227 |
| 10426523 | 10072392 | 0 | 47.3 | null | 2018-09-21 | 2018-10-12 | ECX | N | null | EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100706425 |
| 10426962 | 10072393 | null | null | null | 2020-05-20 | 2020-05-20 | Carboplatin + Cetux + FU (Cycle 1) | 02 | null | VISMODEGIB | 100865963 |
| 10427505 | 10072394 | 1.59 | 0 | null | 2021-08-04 | 2021-08-12 | null | 02 | null | NILOTINIB | 100477650 |
| 10431192 | 10072398 | null | null | 03 | 2022-03-24 | 2022-03-24 | CAPECITABINE + CARBOPLATIN | 02 | N | TRASTUZUMAB EMTANSINE | 101121873 |
| 10431408 | 10072399 | 1.78 | 78 | null | 2022-03-29 | 2022-04-06 | Durvalumab | 02 | null | CAPECITABINE + CARBOPLATIN | 100352002 |
| 10431550 | 10072400 | 1.69 | 46.7 | Adjuvant (A) | 2019-09-28 | 2019-10-10 | Cisplatin + Pemetrexed | 02 | N | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 101823083 |
| 10434009 | 10072402 | null | null | Curative (C) | 2020-03-15 | 2020-03-16 | MELPHALAN + THALIDOMIDE | 02 | N | GEMCITABINE + RITUXIMAB | 101751455 |
| 10436800 | 10072405 | 1.71 | 94 | Adjuvant (A) | null | 2018-04-26 | EVEROLIMUS + EXEMESTANE | 02 | N | OSIMERTINIB | 101460756 |
| 10439777 | 10072411 | 1.87 | 63.6 | null | 2021-11-12 | 2021-11-29 | LORLATINIB | null | null | CLADRIBINE | 101179068 |
| 10443050 | 10072414 | null | 61.6 | Curative (C) | 2019-02-12 | 2019-02-28 | CARBOPLATIN + FLUOROURACIL | 02 | N | BEXAROTENE | 100517493 |
| 10443345 | 10072415 | 1.65 | 59 | null | 2021-12-25 | 2021-12-25 | EC | 02 | null | ABEMACICLIB + FULVESTRANT | 101810969 |
| 10443658 | 10072416 | 1.78 | 90 | Palliative (P) | 2019-11-15 | 2019-11-16 | EVEROLIMUS + EXEMESTANE | null | N | UKALL60+ | 100368663 |
| 10444165 | 10072417 | null | null | Adjuvant (A) | 2019-08-23 | 2019-08-31 | AZACITIDINE + VENETOCLAX | N | N | CRIZOTINIB | 100926689 |
| 10444770 | 10072418 | 0 | 85 | Palliative (P) | 2021-09-24 | 2021-10-12 | null | 02 | N | BEVACIZUMAB | 101371771 |
| 10445399 | 10072419 | 1.64 | 82.3 | null | 2019-02-11 | 2019-02-11 | Cyclophosphamide + Docetaxel + Trastuzumab | 02 | null | OBINUTUZUMAB + VENETOCLAX | 100709390 |
| 10448427 | 10072420 | 1.66 | 66 | Palliative (P) | 2019-04-15 | 2019-04-21 | Bevacizumab 7.5mg/kg | 02 | N | ISATUXIMAB + POMALIDOMIDE | 100597119 |
| 10449361 | 10072421 | 1.68 | 87 | Curative (C) | 2020-06-11 | 2020-06-27 | Olaparib | 02 | null | IXAZOMIB | 101620296 |
| 10451466 | 10072422 | null | 77.1 | Palliative (P) | 2017-11-16 | 2019-12-24 | Mitomycin Intravesical | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101657859 |
| 10451624 | 10072423 | 1.71 | 85 | Palliative (P) | 2020-03-18 | 2020-03-19 | CLARITY Trial | 02 | N | BEXAROTENE | 100630641 |
| 10456315 | 10072426 | 1.54 | 56 | null | 2020-05-22 | 2021-01-26 | DOCETAXEL + GEMCITABINE | 02 | null | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | 100751880 |
| 10457185 | 10072427 | null | null | Palliative (P) | 2018-11-29 | 2018-12-05 | Binimetinib + Encorafenib | N | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101304930 |
| 10461875 | 10072429 | 1.89 | 56.7 | Disease modification (D) | 2016-04-04 | 2017-03-21 | Fulvestrant + Palbociclib | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101721378 |